Literature DB >> 4804285

The cellular immune response to carcinoma of the urinary bladder: correlation to clinical stage and treatment.

C O'Toole, B Unsgaard, L E Almgård, B Johansson.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4804285      PMCID: PMC2149077     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


× No keyword cloud information.
  16 in total

1.  Blood lymphocyte replicating ability as a measurement of radiation dosage.

Authors:  P L Ilbery; A B Rickinson; C E Thrum
Journal:  Br J Radiol       Date:  1971-11       Impact factor: 3.039

Review 2.  Cellular immunity against tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Cancer Res       Date:  1969       Impact factor: 6.242

3.  An extension of the 51Cr-release assay for the estimation of mouse cytotoxins.

Authors:  W Boyle
Journal:  Transplantation       Date:  1968-09       Impact factor: 4.939

4.  Immune response to urinary bladder tumours in man.

Authors:  J Bubeník; P Perlmann; K Helmstein; G Moberger
Journal:  Int J Cancer       Date:  1970-01-15       Impact factor: 7.396

5.  A microassay for cell-mediated immunity.

Authors:  M Takasugi; E Klein
Journal:  Transplantation       Date:  1970-03       Impact factor: 4.939

6.  Cellular and humoral immune responses to human urinary bladder carcinomas.

Authors:  J Bubeník; P Perlmann; K Helmstein; G Moberger
Journal:  Int J Cancer       Date:  1970-05-15       Impact factor: 7.396

7.  Evolution of cell-mediated immunity in mice bearing an antigenic tumor. Influence of tumor growth and surgical removal.

Authors:  G Barski; J K Youn
Journal:  J Natl Cancer Inst       Date:  1969-07       Impact factor: 13.506

8.  Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years.

Authors:  A Bergkvist; A Ljungqvist; G Moberger
Journal:  Acta Chir Scand       Date:  1965-10

9.  Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.

Authors:  M G Lewis; R L Ikonopisov; R C Nairn; T M Phillips; G H Fairley; D C Bodenham; P Alexander
Journal:  Br Med J       Date:  1969-09-06

10.  A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosone pattern and ultrastructure.

Authors:  C C Rigby; L M Franks
Journal:  Br J Cancer       Date:  1970-12       Impact factor: 7.640

View more
  7 in total

Review 1.  Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder.

Authors:  J Bubeník
Journal:  Int Urol Nephrol       Date:  1975       Impact factor: 2.370

2.  Tumour markers in urology: aids in cancer diagnosis and management.

Authors:  B Wahren
Journal:  Urol Res       Date:  1979-06-22

3.  Tumour-directed leucocyte migration inhibition in operable breast cancer: additional clinical correlations.

Authors:  B M Jones; C E Connolly; P Isaacson; D T Turner; A R Turnbull
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

4.  Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker.

Authors:  C O'Toole; V Stejskal; P Perlmann; M Karlsson
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

5.  Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.

Authors:  J H Marti; D M Thomson
Journal:  Br J Cancer       Date:  1976-08       Impact factor: 7.640

6.  The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.

Authors:  M Lopez; R O'Connor; J K MacFarlane; D M Thomson
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

7.  Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma.

Authors:  C O'Toole; Z H Price; Y Ohnuki; B Unsgaard
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.